Расширенный поиск

Сложная астма

Полный текст:

Об авторах

Л. М. Огородова
Сибирский государственный медицинский университет

Ф. И. Петровский
Сибирский государственный медицинский университет

Ю. А. Петровская
Сибирский государственный медицинский университет

О. С. Кобякова
Сибирский государственный медицинский университет

Список литературы

1. Adcock I.M., Lane S.J., Brown C.R. et al. Differences in binding of glucocorticoid receptor to DNA in steroid-resistant asthma. J. Immunol. 1995; 154: 3500-3505.

2. Adcock I.М., Gilbey Т., Gelder C.M. et al. Glucocorticoid receptor localization in normal and asthmatic lung. Am. J. Respir. Crit. Care. Med. 1996; 154: 771-782.

3. Approaches to the Difficult-to-Treat Patient. Symposium held during the American College of Allergy, Asthma and Immunology, Annual Meeting, November 10-15, 1995,

4. Ayres J.G., Miles J.F., Barnes P.J. Brittle asthma. Thorax 1998; 53: 315-321.

5. Barnes P.S., Adcock I.M. Steroid resistance in asthma Quart. J. Med. 1995; 88: 455-468.

6. Busse W.W., Chervinsky P., Condemi J. et al. Budesonide delivered by Turbuhaler is effective in a dose-dependent fashion when used in the treatment of adult patients with chronic asthma. J. Allergy Clin. Immunol. 1998; 101: 457-463.

7. Call R.S., Ward G., Jackson S., Platts-Mills T.A. Investigating severe and fatal asthma. Ibid. 1994; 94: 1065-1072.

8. Corren J., A d in o ff A.D., Buchmeier A.D., Irvin C.G. Nasal beclomethasone prevents the seasonal increase in bronchia] responsiveness in patients with allergic rhinitis and asthma. Ibid. 1992; 90: 250-256.

9. Dahl R., Lundback B., Malo J.L. et al. A dose-ranging study of fluticasone propitiate in adult patients with moderate asthma. International Study Group. Chest 1993; 104: 1352-1358.

10. Difficult asthma / Ed. S. Holgate. London: Dunitz Martin LTD; 1999.

11. Difficult/therapy-resistant asthma. ERS Task Force on Difficult/therapy-resistant asthma. Eur. Respir. J. 1999; 13: 1198.

12. Global initiative for asthma. Global strategy for asthma management and prevention: N H L B I/W H O Workshop Report. No. 95-3659. Bethesda: National Institutes of Health; 1995: 1-176.

13. Greening A.P., Ind P.W., Northfield М., Shaw G. Added salmeterol versus higher-dose corticosteroid in asthma patients with symptoms on existing inhaled corticosteroid. Allen&Hanburys Limited UK Study Group. Lancet 1994; 344: 219-224.

14. Gustafsson P.M., Kjellman N.I., Tibbling L. Oesophageal function and symptoms in moderate and severe asthma. Acta Paediatr. Scand. 1986; 75: 729-736.

15. Hahn D.L., Dodge R.W., Golubjatnikov R. Association of Chlamydia pneumonia (strain TWAR) infection with wheezing, asthmatic bronchitis, and adult-onset. JAMA. 1991; 266: 225-230.

16. Harper P.C., Bergner A., Kaye M.D. Antireflux treatment for asthma. Improvement in patients with associated gastroesophageal reflux Arch. Intern. Med. 1987; 147: 56-60.

17. Hetzel M.R. Brittle asthma: Fiend or phantom? Thorax 1998; 53: 235-236.

18. Hunt L.W., Swedlund H.A., Gleich G.J. Effect of nebulized lidocaine on severe glucocorticoid-dependent asthma Mayo Clin. Proc. 1996; 71: 361-368.

19. Irwin R.S., Curley F.J., French C.L. Difficult to control asthma. Contributing factors and outcome of a systematic management protocol. Chest 1993; 103: 1662-1669.

20. Kelloway J.S., Wyatt R.A., Adlis S.A. Comparison of patients’ compliance with prescribed oral and inhaled asthma medications. Arch. Intern. Med. 1994; 154: 1349-1352.

21. Lock S.H., Kay A.B., Barnes N.C. Double-blind, placebo-controlled study of cyclosporin A as a corticosteroid-sparing agent in corticosteroid-dependent asthma. Am. J. Respir. Crit. Care Med. 1996; 153: 509-514.

22. Maeda Y., Akiyama K., Hayakawa T. et al. A new steroid therapy for difficult asthmatics — an induction and maintenance, two-step therapy. Arerugi 1992; 41: 1687-1693.

23. Martin M.E., Grunstein M.M., Larsen G.L. The relationship of gastroesophageal reflux to nocturnal wheezing in children with asthma. Ann. Allergy 1982; 49: 318-322.

24. Mazer B.D., Gelfand E.W. An open-label study of high-dose intravenous immunoglobulin in severe childhood asthma. J. Allergy Clin. Immunol. 1991; 87: 976-983.

25. National asthma education and prevention program. Expert panel report 2: Guidelines for the diagnosis and management of asthma. National Heart, Lung, and Blood Institute, National Institutes of Health publ. no 97-4051. Bethesda; MD; 1997.

26. Nierop G., Gijzel W.P., Bel E.H. et al. Auranofin in the treatment of steroid dependent asthma: a double blind study. Thorax 1992; 47: 349-354.

27. Pauwels R.A., Lofdahl C., Postma D. et al. Effect of inhaled formoterol and budesonide on exacerbations of asthma. N. Engl. J. Med. 1997; 337: 1405-1411.

28. Reiss T.F., Chervinsky P., Dockhorn R.J. et al. Montelukast, a once-daily leukotriene receptor antagonist, in the treatment of chronic asthma: a multicenter, randomized, double-blind trial. Montelukast Clinical Research Study Groups. Arch. Intern. Med. 1998; 158: 1213-1220.

29. Schwartz H.J., Lowell F.C., Melby J.C. Steroid resistance in bronchial asthma. Ann. Intern. Med. 1968; 69: 493-498.

30. Spaulding H.S. Jr., Mansfield L.E., Stein M.R. et al. Further investigation of the association between gastroesophageal reflux and bronchoconstriction. J. Allergy Clin. Immunol. 1982; 69: 516-521.

31. Spector S.L., Smith L.J., Glass M. Effects of six weeks of therapy with oral doses of ICI 204, 219, a leukotriene D4 receptor antagonist, in subjects with bronchial asthma. Am. J. Respir. Crit. Care Med. 1994; 150: 618-623.

32. Turner-Warwick M. On observing patterns of airflow obstruction in chronic asthma. Br. J. Dis. Chest 1977; 71: 73-78.

33. Thomas P.S., Geddes D.M., Barnes P.J. Pseudo-steroid resistant asthma. Thorax 1999; 54: 352-356.

Для цитирования:

Огородова Л.М., Петровский Ф.И., Петровская Ю.А., Кобякова О.С. Сложная астма. Пульмонология. 2001;(1):94-100.

For citation:

Ogorodova L.M., Petrovsky F.I., Petrovskaya Yu.I., Kobyakova O.S. Difficult asthma. PULMONOLOGIYA. 2001;(1):94-100. (In Russ.)

Просмотров: 7

ISSN 0869-0189 (Print)
ISSN 2541-9617 (Online)